Skip to main content
Erschienen in: Abdominal Radiology 6/2016

04.04.2016

Small (<4 cm) clear cell renal cell carcinoma: correlation between CT findings and histologic grade

verfasst von: Soo Yeon Choi, Deuk Jae Sung, Kyung Sook Yang, Kyeong Ah Kim, Suk Keu Yeom, Ki Choon Sim, Na Yeon Han, Beom Jin Park, Min Ju Kim, Sung Bum Cho, Jeong Hyeon Lee

Erschienen in: Abdominal Radiology | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate the correlation between CT findings and histologic grade of small clear cell renal cell carcinoma (ccRCC).

Methods

CT scans of 101 patients with small ccRCC were reviewed independently by two radiologists for tumor size, shape, margin, encapsulation, enhancement pattern, and visual relative enhancement. Enhancement patterns were defined according to the percentage of uniform enhancement [pattern 1, homogeneous (≥90%); pattern 2, relatively homogeneous (≥75 and <90%); and pattern 3, heterogeneous (<75%)]. Quantitative parameters representing attenuation and degree of enhancement were calculated. Histologic grade was classified as low (Fuhrman grade I or II) and high (Fuhrman grade III or IV). CT imaging variables were analyzed using univariate and multivariate analyses.

Results

A total of 63 low-grade and 38 high-grade small ccRCCs were assessed. Low-grade tumors differed from high-grade tumors with respect to enhancement pattern 1 or 2 (p < 0.001 and p < 0.001), smaller size (p = 0.002 and p = 0.001), and lower attenuation on unenhanced scan (p < 0.001 and p = 0.008). In multivariate analysis, enhancement pattern 1 or 2 and low attenuation (≤30 HU) were identified as independent predictors of low-grade ccRCC. Accuracy derived from logistic regression analysis was 79.2% for reader 1 and 70.3% for reader 2.

Conclusions

CT imaging features including tumor attenuation and enhancement pattern can be useful to predict the biologic behavior of small ccRCC for adequate treatment strategy.
Literatur
1.
Zurück zum Zitat Ljungberg B, Bensalah K, Canfield S, et al. (2015) EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 67:913–924CrossRefPubMed Ljungberg B, Bensalah K, Canfield S, et al. (2015) EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 67:913–924CrossRefPubMed
2.
Zurück zum Zitat Rendon RA, Jewett MA (2006) Expectant management for the treatment of small renal masses. Urol Oncol 24:62–67CrossRefPubMed Rendon RA, Jewett MA (2006) Expectant management for the treatment of small renal masses. Urol Oncol 24:62–67CrossRefPubMed
3.
Zurück zum Zitat Pahernik S, Ziegler S, Roos F, Melchior SW, Thüroff JW (2007) Small renal tumors: correlation of clinical and pathological features with tumor size. J Urol 178:414–417CrossRefPubMed Pahernik S, Ziegler S, Roos F, Melchior SW, Thüroff JW (2007) Small renal tumors: correlation of clinical and pathological features with tumor size. J Urol 178:414–417CrossRefPubMed
4.
Zurück zum Zitat Donat SM, Diaz M, Bishoff JT, et al. (2013) Follow-up for clinically localized renal neoplasms: AUA guideline. J Urol 190:407–416CrossRefPubMed Donat SM, Diaz M, Bishoff JT, et al. (2013) Follow-up for clinically localized renal neoplasms: AUA guideline. J Urol 190:407–416CrossRefPubMed
5.
Zurück zum Zitat Silverman SG, Israel GM, Trinh QD (2015) Incompletely characterized incidental renal masses: emerging data support conservative management. Radiology 275:28–42CrossRefPubMed Silverman SG, Israel GM, Trinh QD (2015) Incompletely characterized incidental renal masses: emerging data support conservative management. Radiology 275:28–42CrossRefPubMed
7.
Zurück zum Zitat Fuhrman SA, Lasky LC, Limas C (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6:655–663CrossRefPubMed Fuhrman SA, Lasky LC, Limas C (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6:655–663CrossRefPubMed
8.
Zurück zum Zitat Ficarra V, Righetti R, Martignoni G, et al. (2001) Prognostic value of renal cell carcinoma nuclear grading: multivariate analysis of 333 cases. Urol Int 67:130–134CrossRefPubMed Ficarra V, Righetti R, Martignoni G, et al. (2001) Prognostic value of renal cell carcinoma nuclear grading: multivariate analysis of 333 cases. Urol Int 67:130–134CrossRefPubMed
9.
Zurück zum Zitat Volpe A, Mattar K, Finelli A, et al. (2008) Contemporary results of percutaneous biopsy of 100 small renal masses: a single center experience. J Urol 180:2333–2337CrossRefPubMed Volpe A, Mattar K, Finelli A, et al. (2008) Contemporary results of percutaneous biopsy of 100 small renal masses: a single center experience. J Urol 180:2333–2337CrossRefPubMed
10.
Zurück zum Zitat Leveridge MJ, Finelli A, Kachura JR, et al. (2011) Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy. Eur Urol 60:578–584CrossRefPubMed Leveridge MJ, Finelli A, Kachura JR, et al. (2011) Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy. Eur Urol 60:578–584CrossRefPubMed
11.
Zurück zum Zitat Harris CR, Whitson JM, Meng MV (2012) Under-grading of <4 cm renal masses on renal biopsy. BJU Int 110:794–797CrossRefPubMed Harris CR, Whitson JM, Meng MV (2012) Under-grading of <4 cm renal masses on renal biopsy. BJU Int 110:794–797CrossRefPubMed
12.
Zurück zum Zitat Villalobos-Gollás M, Aguilar-Davidov B, Culebro-García C, et al. (2012) Pathological implications of areas of lower enhancement on contrast-enhanced computed tomography in renal-cell carcinoma: additional information for selecting candidates for surveillance protocols. Int Urol Nephrol 44:1369–1374CrossRefPubMed Villalobos-Gollás M, Aguilar-Davidov B, Culebro-García C, et al. (2012) Pathological implications of areas of lower enhancement on contrast-enhanced computed tomography in renal-cell carcinoma: additional information for selecting candidates for surveillance protocols. Int Urol Nephrol 44:1369–1374CrossRefPubMed
13.
Zurück zum Zitat Vargas HA, Delaney HG, Delappe EM, et al. (2013) Multiphasic contrast-enhanced MRI: single-slice versus volumetric quantification of tumor enhancement for the assessment of renal clear-cell carcinoma fuhrman grade. J Magn Reson Imaging 37:1160–1167CrossRefPubMedPubMedCentral Vargas HA, Delaney HG, Delappe EM, et al. (2013) Multiphasic contrast-enhanced MRI: single-slice versus volumetric quantification of tumor enhancement for the assessment of renal clear-cell carcinoma fuhrman grade. J Magn Reson Imaging 37:1160–1167CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Kwon YK, Kim BH, Park CH, Kim CI, Chang HS (2009) Effectiveness of computed tomography for predicting the nuclear grade of renal cell carcinoma. Korean J Urol 50:942–946CrossRef Kwon YK, Kim BH, Park CH, Kim CI, Chang HS (2009) Effectiveness of computed tomography for predicting the nuclear grade of renal cell carcinoma. Korean J Urol 50:942–946CrossRef
16.
Zurück zum Zitat Zhu YH, Wang X, Zhang J, et al. (2014) Low enhancement on multiphase contrast-enhanced CT images: an independent predictor of the presence of high tumor grade of clear cell renal cell carcinoma. AJR Am J Roentgenol 203:W295–W300CrossRefPubMed Zhu YH, Wang X, Zhang J, et al. (2014) Low enhancement on multiphase contrast-enhanced CT images: an independent predictor of the presence of high tumor grade of clear cell renal cell carcinoma. AJR Am J Roentgenol 203:W295–W300CrossRefPubMed
17.
Zurück zum Zitat Young JR, Margolis D, Sauk S, et al. (2013) Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT. Radiology 267:444–453CrossRefPubMed Young JR, Margolis D, Sauk S, et al. (2013) Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT. Radiology 267:444–453CrossRefPubMed
18.
Zurück zum Zitat Halverson SJ, Kunju LP, Bhalla R, et al. (2013) Accuracy of determining small renal mass management with risk stratified biopsies: confirmation by final pathology. J Urol 189:441–446CrossRefPubMed Halverson SJ, Kunju LP, Bhalla R, et al. (2013) Accuracy of determining small renal mass management with risk stratified biopsies: confirmation by final pathology. J Urol 189:441–446CrossRefPubMed
19.
Zurück zum Zitat Lebret T, Poulain JE, Molinie V, et al. (2007) Percutaneous core biopsy for renal masses: indications, accuracy and results. J Urol 178:1184–1188CrossRefPubMed Lebret T, Poulain JE, Molinie V, et al. (2007) Percutaneous core biopsy for renal masses: indications, accuracy and results. J Urol 178:1184–1188CrossRefPubMed
20.
Zurück zum Zitat Laguna MP, Kümmerlin I, Rioja J, de la Rosette JJ (2009) Biopsy of a renal mass: where are we now? Curr Opin Urol 19:447–453CrossRefPubMed Laguna MP, Kümmerlin I, Rioja J, de la Rosette JJ (2009) Biopsy of a renal mass: where are we now? Curr Opin Urol 19:447–453CrossRefPubMed
21.
Zurück zum Zitat Pablo C, Marcela G, Lía EA, María IA (2012) Correlation between MVD and two prognostic factors: Fuhrman grade and tumoral size, in clear cell renal cell carcinoma. J Cancer Sci Ther 4:313–316CrossRef Pablo C, Marcela G, Lía EA, María IA (2012) Correlation between MVD and two prognostic factors: Fuhrman grade and tumoral size, in clear cell renal cell carcinoma. J Cancer Sci Ther 4:313–316CrossRef
22.
Zurück zum Zitat Wang JH, Min PQ, Wang PJ, et al. (2006) Dynamic CT evaluation of tumor vascularity in renal cell carcinoma. AJR Am J Roentgenol 186:1423–1430CrossRefPubMed Wang JH, Min PQ, Wang PJ, et al. (2006) Dynamic CT evaluation of tumor vascularity in renal cell carcinoma. AJR Am J Roentgenol 186:1423–1430CrossRefPubMed
23.
Zurück zum Zitat Jinzaki M, Tanimoto A, Mukai M, et al. (2000) Double-phase helical CT of small renal parenchymal neoplasms: correlation with pathologic findings and tumor angiogenesis. J Comput Assist Tomogr 24:835–842CrossRefPubMed Jinzaki M, Tanimoto A, Mukai M, et al. (2000) Double-phase helical CT of small renal parenchymal neoplasms: correlation with pathologic findings and tumor angiogenesis. J Comput Assist Tomogr 24:835–842CrossRefPubMed
24.
Zurück zum Zitat Birnbaum BA, Bosniak MA, Krinsky GA, et al. (1994) Renal cell carcinoma: correlation of CT findings with nuclear morphologic grading in 100 tumors. Abdom Imaging 19:262–266CrossRefPubMed Birnbaum BA, Bosniak MA, Krinsky GA, et al. (1994) Renal cell carcinoma: correlation of CT findings with nuclear morphologic grading in 100 tumors. Abdom Imaging 19:262–266CrossRefPubMed
25.
Zurück zum Zitat Birnbaum BA, Bosniak MA, Megibow AJ, Lubat E, Gordon RB (1990) Observations on the growth of renal neoplasms. Radiology 176:695–701CrossRefPubMed Birnbaum BA, Bosniak MA, Megibow AJ, Lubat E, Gordon RB (1990) Observations on the growth of renal neoplasms. Radiology 176:695–701CrossRefPubMed
26.
Zurück zum Zitat Yu M, Wang H, Zhao J, et al. (2013) Expression of CIDE proteins in clear cell renal cell carcinoma and their prognostic significance. Mol Cell Biochem 378:145–151CrossRefPubMedPubMedCentral Yu M, Wang H, Zhao J, et al. (2013) Expression of CIDE proteins in clear cell renal cell carcinoma and their prognostic significance. Mol Cell Biochem 378:145–151CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Thoenes W, Störkel S, Rumpelt H (1986) Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Pathol Res Pract 181:125–143CrossRefPubMed Thoenes W, Störkel S, Rumpelt H (1986) Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Pathol Res Pract 181:125–143CrossRefPubMed
28.
Zurück zum Zitat Yao M, Tabuchi H, Nagashima Y, et al. (2005) Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma. J Pathol 205:377–387CrossRefPubMed Yao M, Tabuchi H, Nagashima Y, et al. (2005) Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma. J Pathol 205:377–387CrossRefPubMed
29.
Zurück zum Zitat Yao M, Huang Y, Shioi K, et al. (2007) Expression of adipose differentiation-related protein: a predictor of cancer-specific survival in clear cell renal carcinoma. Clin Cancer Res 13:152–160CrossRefPubMed Yao M, Huang Y, Shioi K, et al. (2007) Expression of adipose differentiation-related protein: a predictor of cancer-specific survival in clear cell renal carcinoma. Clin Cancer Res 13:152–160CrossRefPubMed
30.
Zurück zum Zitat Hsu RM, Chan DY, Siegelman SS (2004) Small renal cell carcinomas: correlation of size with tumor stage, nuclear grade, and histologic subtype. AJR Am J Roentgenol 182:551–557CrossRefPubMed Hsu RM, Chan DY, Siegelman SS (2004) Small renal cell carcinomas: correlation of size with tumor stage, nuclear grade, and histologic subtype. AJR Am J Roentgenol 182:551–557CrossRefPubMed
31.
Zurück zum Zitat Duffey BG, Choyke PL, Glenn G, et al. (2004) The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease. J Urol 172:63–65CrossRefPubMed Duffey BG, Choyke PL, Glenn G, et al. (2004) The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease. J Urol 172:63–65CrossRefPubMed
32.
Zurück zum Zitat Ro JY, Ayala AG, Sella A, Samuels ML, Swanson DA (1987) Sarcomatoid renal cell carcinoma: clinicopathologic. A study of 42 cases. Cancer 59:516–526CrossRefPubMed Ro JY, Ayala AG, Sella A, Samuels ML, Swanson DA (1987) Sarcomatoid renal cell carcinoma: clinicopathologic. A study of 42 cases. Cancer 59:516–526CrossRefPubMed
33.
Zurück zum Zitat Jeldres C, Sun M, Liberman D, et al. (2009) Can renal mass biopsy assessment of tumor grade be safely substituted for by a predictive model? J Urol 182:2585–2589CrossRefPubMed Jeldres C, Sun M, Liberman D, et al. (2009) Can renal mass biopsy assessment of tumor grade be safely substituted for by a predictive model? J Urol 182:2585–2589CrossRefPubMed
34.
Zurück zum Zitat Al-Aynati M, Chen V, Salama S, et al. (2003) Interobserver and intraobserver variability using the Fuhrman grading system for renal cell carcinoma. Arch Patholol Lab Med 127:593–596 Al-Aynati M, Chen V, Salama S, et al. (2003) Interobserver and intraobserver variability using the Fuhrman grading system for renal cell carcinoma. Arch Patholol Lab Med 127:593–596
Metadaten
Titel
Small (<4 cm) clear cell renal cell carcinoma: correlation between CT findings and histologic grade
verfasst von
Soo Yeon Choi
Deuk Jae Sung
Kyung Sook Yang
Kyeong Ah Kim
Suk Keu Yeom
Ki Choon Sim
Na Yeon Han
Beom Jin Park
Min Ju Kim
Sung Bum Cho
Jeong Hyeon Lee
Publikationsdatum
04.04.2016
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 6/2016
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-016-0732-9

Weitere Artikel der Ausgabe 6/2016

Abdominal Radiology 6/2016 Zur Ausgabe

Classics in Abdominal Imaging

The “beak” sign

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.